Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IL27 Antikörper (FITC)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch IL27 in FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN1107838

Kurzübersicht für IL27 Antikörper (FITC) (ABIN1107838)

Target

Alle IL27 Antikörper anzeigen
IL27 (Interleukin-27 Subunit alpha (IL27))

Reaktivität

  • 18
  • 15
  • 14
Human

Wirt

  • 21
  • 5
Maus

Klonalität

  • 21
  • 5
Monoklonal

Konjugat

  • 18
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IL27 Antikörper ist konjugiert mit FITC

Applikation

  • 15
  • 10
  • 9
  • 9
  • 3
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Klon

B-G49
  • Spezifität

    Recognizes both natural and recombinant Human IL-27

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human.

    Aufreinigung

    Ion Exchange Chromatography.

    Immunogen

    Recombinant Human IL-27.

    Isotyp

    IgG2a
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 5 % BSA as stabilizer and 0.09 % Sodium Azide as preservative.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C.
  • Target

    IL27 (Interleukin-27 Subunit alpha (IL27))

    Andere Bezeichnung

    Interleukin-27 / IL27A

    Hintergrund

    Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naive but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet.Synonyms: IL-27 subunit alpha, IL-30, IL27-A, IL30, Interleukin-30, p28

    Gen-ID

    246778

    NCBI Accession

    NP_663634

    UniProt

    Q8NEV9
Sie sind hier:
Chat with us!